5.42MMarket Cap
LossP/E TTM
ENDRA Life Sciences Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of ENDRA Life Sciences Inc is 8.83, ranking 48 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.58, which is -103.84% below the recent high of 0.02 and -90.15% above the recent low of -1.09.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.